Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes

Recent studies demonstrate that immune checkpoint inhibitor (ICI) therapy has achieved success in many types of advanced cancers including advanced hepatocellular carcinoma (HCC). However, ICI therapy is beneficial in only some HCC patients, suggesting that immune-responses are highly variable in HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Di, Chen, Meng-Ke, Zhang, Qing-Feng, Zhou, Yu-Feng, Zhang, Mei-Yin, Mai, Shi-Juan, Zhang, Yao-Jun, Chen, Min-Shan, Li, Xiao-Xing, Wang, Hui-Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343492/
https://www.ncbi.nlm.nih.gov/pubmed/32544882
http://dx.doi.org/10.18632/aging.103395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343492/
https://www.ncbi.nlm.nih.gov/pubmed/32544882
http://dx.doi.org/10.18632/aging.103395

Ejemplares similares